| Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review JD Merker, GR Oxnard, C Compton, M Diehn, P Hurley, AJ Lazar, ... Archives of pathology & laboratory medicine 142 (10), 1242-1253, 2018 | 948 | 2018 |
| Future supply and demand for oncologists: challenges to assuring access to oncology services C Erikson, E Salsberg, G Forte, S Bruinooge, M Goldstein Journal of oncology practice 3 (2), 79-86, 2007 | 586 | 2007 |
| Improving the evidence base for treating older adults with cancer: American Society of Clinical Oncology statement A Hurria, LA Levit, W Dale, SG Mohile, HB Muss, L Fehrenbacher, ... Journal of Clinical Oncology 33 (32), 3826-3833, 2015 | 423 | 2015 |
| Broadening eligibility criteria to make clinical trials more representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement ES Kim, SS Bruinooge, S Roberts, G Ison, NU Lin, L Gore, TS Uldrick, ... Journal of Clinical Oncology 35 (33), 3737, 2017 | 400 | 2017 |
| Modernizing clinical trial eligibility criteria: recommendations of the American Society of Clinical Oncology–Friends of Cancer Research HIV working group TS Uldrick, G Ison, MA Rudek, A Noy, K Schwartz, S Bruinooge, ... Journal of clinical oncology: official journal of the American Society of …, 2017 | 313 | 2017 |
| Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage W Yang, JH Williams, PF Hogan, SS Bruinooge, GI Rodriguez, MP Kosty, ... Journal of oncology practice 10 (1), 39-45, 2014 | 239 | 2014 |
| Association between geographic access to cancer care, insurance, and receipt of chemotherapy: geographic distribution of oncologists and travel distance CC Lin, SS Bruinooge, MK Kirkwood, C Olsen, A Jemal, D Bajorin, ... Journal of Clinical Oncology 33 (28), 3177-3185, 2015 | 231 | 2015 |
| Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: findings from an American Society of Clinical Oncology Survey DM Waterhouse, RD Harvey, P Hurley, LA Levit, ES Kim, HD Klepin, ... JCO Oncology Practice 16 (7), 417-421, 2020 | 200 | 2020 |
| Reviewing cancer care team effectiveness SH Taplin, S Weaver, E Salas, V Chollette, HM Edwards, SS Bruinooge, ... Journal of oncology practice 11 (3), 239-246, 2015 | 166 | 2015 |
| Rationale and design of the targeted agent and profiling utilization registry study PK Mangat, S Halabi, SS Bruinooge, E Garrett-Mayer, A Alva, ... JCO precision oncology 2, 1-14, 2018 | 162 | 2018 |
| The National Cancer Institute–American Society of Clinical Oncology cancer trial accrual symposium: summary and recommendations AM Denicoff, W McCaskill-Stevens, SS Grubbs, SS Bruinooge, RL Comis, ... Journal of oncology practice 9 (6), 267-276, 2013 | 151 | 2013 |
| The state of oncology practice in America, 2018: results of the ASCO practice census survey MK Kirkwood, A Hanley, SS Bruinooge, E Garrett-Mayer, LA Levit, ... Journal of Oncology Practice 14 (7), e412-e420, 2018 | 135 | 2018 |
| American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment JS Weber, LA Levit, PC Adamson, S Bruinooge, HA Burris, MA Carducci, ... Journal of Clinical Oncology 33 (3), 278, 2015 | 120 | 2015 |
| Pembrolizumab in patients with metastatic breast cancer with high tumor mutational burden: results from the targeted agent and profiling utilization registry (TAPUR) study AS Alva, PK Mangat, E Garrett-Mayer, S Halabi, D Hansra, CJ Calfa, ... Journal of clinical oncology 39 (22), 2443-2451, 2021 | 108 | 2021 |
| Teams and teamwork during a cancer diagnosis: interdependency within and between teams SH Taplin, S Weaver, V Chollette, LB Marks, A Jacobs, G Schiff, ... Journal of oncology practice 11 (3), 231-238, 2015 | 107 | 2015 |
| Understanding the role of advanced practice providers in oncology in the United States SS Bruinooge, TA Pickard, W Vogel, A Hanley, C Schenkel, ... Journal of Oncology Practice 14 (9), e518-e532, 2018 | 102 | 2018 |
| Palbociclib in Patients With Pancreatic and Biliary Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study T Al Baghdadi, S Halabi, E Garrett-Mayer, PK Mangat, ER Ahn, V Sahai, ... JCO Precision Oncology 1, 1-8, 2019 | 97 | 2019 |
| Association between geographic access to cancer care and receipt of radiation therapy for rectal cancer CC Lin, SS Bruinooge, MK Kirkwood, DL Hershman, A Jemal, ... International Journal of Radiation Oncology* Biology* Physics 94 (4), 719-728, 2016 | 95 | 2016 |
| Modernizing eligibility criteria for molecularly driven trials ES Kim, D Bernstein, SG Hilsenbeck, CH Chung, AP Dicker, JL Ersek, ... Journal of Clinical Oncology 33 (25), 2815-2820, 2015 | 95 | 2015 |
| Increasing racial and ethnic diversity in cancer clinical trials: an American Society of Clinical Oncology and Association of Community Cancer Centers joint research statement RA Oyer, P Hurley, L Boehmer, SS Bruinooge, K Levit, N Barrett, ... Journal of Clinical Oncology 40 (19), 2163-2171, 2022 | 91 | 2022 |
